Related Experiment Video
Updated: Oct 29, 2025

Quantification of Monocyte Transmigration and Foam Cell Formation from Individuals with Chronic Inflammatory Conditions
Published on: October 17, 2017
Interleukin-36γ aggravates macrophage foam cell formation and atherosclerosis progression in ApoE knockout mice
Minghua Zhang1, Jing Liu2, Rong Gao3
1Clinical Pharmacy Laboratory, Chinese PLA General Hospital, Beijing 100853, China.
Insights
Interleukin-36 gamma (IL-36γ) promotes atherosclerosis by increasing macrophage foam cell formation. This involves upregulating CD36 scavenger receptor expression via the phosphoinositide 3-kinase pathway, highlighting IL-36γ as a key factor in this cardiovascular disease.
Area of Science:
- Cardiovascular Science
- Immunology
- Molecular Biology
Background:
- Atherosclerosis is a leading global cause of mortality.
- Macrophage foam cell formation is a critical early step in atherogenesis.
- The precise molecular mechanisms driving foam cell formation require further elucidation.
Purpose of the Study:
- To investigate the role of Interleukin-36 gamma (IL-36γ) in atherosclerosis pathogenesis.
- To explore how IL-36γ influences macrophage inflammatory and metabolic processes.
Main Methods:
- Studied the effects of IL-36γ on macrophage inflammatory responses and lipoprotein metabolism.
- Investigated IL-36γ's impact on oxidized low-density lipoprotein uptake and foam cell formation.
- Examined the molecular pathways, including the phosphoinositide 3-kinase pathway and CD36 expression, regulated by IL-36γ in macrophages.
Main Results:
- IL-36γ was found to regulate inflammatory responses and lipoprotein metabolism in macrophages.
- IL-36γ promotes atherosclerosis by enhancing macrophage foam cell formation.
- IL-36γ upregulates scavenger receptor CD36 expression via the phosphoinositide 3-kinase pathway in macrophages.
Conclusions:
- IL-36γ is a novel regulator of macrophage foam cell formation.
- IL-36γ plays a significant role in the progression of atherosclerosis.
- Targeting IL-36γ pathways may offer therapeutic strategies for atherosclerosis.
Abstract:
Atherosclerosis-related cardiovascular diseases are the leading cause of mortality worldwide. Macrophage-derived foam cell formation is a critical early event in atherogenesis. However, the molecular pathways involved in this disease have not been fully elucidated. Interleukin (IL)-36 plays a crucial role in inflammation, and this study was conducted to investigate the possible role of IL-36γ in the pathogenesis and regulation of atherosclerosis. In this study, we show that IL-36γ regulates inflammatory responses and lipoprotein metabolic processes in macrophages and exerts its atherosclerosis-promoting effects by increasing macrophage foam cell formation and uptake of oxidized low-density lipoproteins. Mechanistically, IL-36γ specifically upregulates expression of the scavenger receptor CD36 through the phosphoinositide 3-kinase pathway in macrophages. These results contribute to our understanding of IL-36γ as a novel regulator of foam cell formation and atherogenesis progression.
More Related Videos
Related Concept Videos
Inflammation
Atherosclerosis I: Introduction

